Over the last few years, the treatment landscape for patients with multiple myeloma (MM) changed dramatically. Also the 2019 annual meeting of the European Hematology Association featured several interesting MM abstracts. In this article we will discuss 6 highlights from the meeting. For a more complete overview of MM news at EHA 2019 we would like to refer to the congress website (

(BELG J HEMATOL 2019;10(5):203–7)